AGXT and primary hyperoxaluria type 1: PH1 is a life-threatening disease caused by mutations in the AGXT gene leading to impaired activity of the hepatic enzyme alanine-glyoxylate aminotransferase (AGT)5, which catalyzes glyoxylate conversion to glycine (Fig. 1a).